Submitted abstractsEarly stage NSCLC82TiP - IMpower030: Phase III study evaluating neoadjuvant treatment of resectable stage II-IIIB non-small cell lung cancer (NSCLC) with atezolizumab (atezo) + chemotherapy
Early stage NSCLC
Under an Elsevier user license
open archive
Cited by (0)
Copyright © 2019 THE AUTHORS. Published by Elsevier Ltd. All rights reserved.